Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
32 hedge funds and large institutions have $68.3M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
9% more capital invested
Capital invested by funds: $62.8M → $68.3M (+$5.49M)
7% more funds holding
Funds holding: 30 → 32 (+2)
53% less call options, than puts
Call options by funds: $297K | Put options by funds: $636K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$6.85M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$5.41M |
| 3 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$1.95M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$1.82M |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$811K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIG
Fortress Investment Group
New York
|
-$8.23M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$958K |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$631K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$326K |
CORV Hedge Fund Activity: Q1 2015 in Review
32 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q1 2015, worth a combined $68.3M — up 8.7% from $62.8M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CORV positions and 4 closed out — a net gain of 2 holders — while 13 added to existing stakes and 9 trimmed.
The largest buyer was Westfield Capital Management, adding an estimated $6.85M. The largest seller was Fortress Investment Group, exiting entirely with an estimated $8.23M sold.
- 32 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q1 2015, up from 30 in Q4 2014.
- Funds reported $68.3M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q1 2015, up 8.7% quarter-over-quarter.
- 6 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q1 2015 and 4 closed out, a net change of +2 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q1 2015 was Westfield Capital Management, an estimated $6.85M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q1 2015 was Fortress Investment Group, an estimated $8.23M sold.
Based on aggregated 13F filings for Q1 2015.